Yu L, Hu Y, Xu J, Qiao R, et al. Multi-target angiogenesis inhibitor combined with PD-1 inhibitors may benefit advanced non-small cell lung cancer patients in late line after failure of EGFR-TKI therapy. Int J Cancer 2023 Apr 20. doi: 10.1002/ijc.34536.
PMID: 37078587